Contact:
Contact:
Phone: 17-6191
Research Topic:
Development and evaluation of tumor-specific immunotherapies for the treatment of breast cancer
Curriculum Vitae:
| Since 04/2024 | Maternity leave |
| 06/2023 - 03/2024 | PostDoc in the groups of Prof. Edgar Schmitt, Prof. Tobias Bopp and Prof. Pol Besenius, University Medical Center & JGU Mainz |
| 05/2019 - 06/2023 | Ph.D. student in the groups of Prof. Edgar Schmitt and Prof. Pol Besenius, University Medical Center & JGU Mainz |
| 10/2018 - 04/2019 | Master thesis in the group of PD Dr. Udo Hartwig, University Medical Center Mainz |
| 09/2017 - 02/2018 | DAAD-ISAP exchange student in the group of Prof. Robert Batey, University of Toronto, Canada |
| 2016 - 2019 | Master of Science in Biomedical Chemistry, JGU Mainz |
| 05/2016 - 09/2016 | Bachelor thesis in the group of Prof. Tanja Schirmeister, JGU Mainz |
| 2013 - 2016 | Bachelor of Science in Biomedical Chemistry, JGU Mainz |
| 2012 - 2013 | Bachelor of Science in Chemistry, JGU Mainz |
| 2011 - 2012 | Internship as dental assistant |
Publications:
[2] Selective Antibody-Drug Conjugates for Targeted Cancer Therapy.T. Bopp, P. Besenius, R. Attariya-Hefnawy, N. Stergiou, H. Kunz, E. Schmitt, 2024, EP24190636. [1] MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-Type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
A. Gabba*, R. Attariya, S. Behren, C. Pett, J.C. van der Horst, H. Yurugi, J. Yu, M. Urschbach, J. Sabin, G. Birrane, E. Schmitt, S.J. van Vliet‡, P. Besenius‡, U. Westerlind‡, P.V. Murphy‡,
J. Am. Chem. Soc. 2023, 24, 13027-13037. DOI: 10.1021/jacs.2c12843.
(§ joint senior authors)
